Michigan Biomedical Venture Fund

Proud to have our COO Connie Chang present at the Retina Innovation Showcase during the Ophthalmology Innovation Summit. Her presentation highlighted ONL’s pioneering Fas inhibition platform technology and our Dry AMD/GA Phase 1b study data, setting the stage for our upcoming Phase 2 Galaxy Study. Thank you for your leadership and dedication, Connie! #OIS #OISXIV #RetinaInnovation #Neuroprotection #ONL1204 #DryAMD Ophthalmology Innovation Source

We announced today that the U.S Food and Drug Administration (FDA) has granted Breakthrough Device Designation for our NIO® Lung Cancer Reveal image analysis module. “We are excited by the FDA’s decision to grant breakthrough device designation for NIO® Lung Cancer Reveal,“ said Steve Pastore, MD, VP of Clinical Affairs for Invenio Imaging. “This underscores the need to expand access to rapid on-site evaluation of bronchoscopic lung forceps biopsies using AI.” Granting of a Breakthrough Device Designation does not guarantee that the application will ultimately be approved.

Michigan Life Science Entrepreneurs Association (MiLSEA) is thrilled to announce the launch of our annual MiLSEA Startup Business Plan Competition at the Blau Colloquium, Ross, on December 10th to celebrate the holidays with the life science community and offer an exciting opportunity for budding innovators to showcase their ideas and vie for a chance to win a grand prize valued at $50,000!  The best part of the grand prize? You get to partner with ID Ventures, Michigan’s premier early-stage VC! Are you a life science startup based in Michigan with less than $2M raised in fundraising? Then hurry! The deadline for submission is November 20th, 2024! Please apply here for more details: https://lnkd.in/g3a4Uxaz If you have any questions, please write to us at info@milsea.org. We are thrilled to hear about your interest! Also, dear startup community members, please help us spread the word to life science startups. Our aim is to connect life science startups with investors, customers, mentors, like-minded founders, and talent! #entrepreneurship #businessplancompetition #grandprize #lifescience #michigan Matthew Hymes Kalyan Handique Len Middleton Patti Glaza Prem Bodagala Derya Karaarslan

💡 What does it take to advance more research to clinical impact?💡 📣 Hint: Calling all bio / med founders & entrepreneurs! Spread the word! 📣 🧪 Without a company in between, the greatest discoveries in research labs won’t become new treatments, medical technologies and products that can improve lives. 〽️ U-M broke records this year with $2B+ in research (top public research university), 600+ inventions fueling 28 new startups ❓What’s the bottleneck to leveling up even more? 🔗 Matching emerging projects with the best founders / entrepreneurs / business leaders who can launch, build teams and attract resources to move the startups forward. 🚀 My Innovation Partnerships colleagues have just launched a program to directly address this bottleneck: Accelerate Blue Foundry (https://lnkd.in/ggwwda6H) ✋ They are seeking founding startup CEOs to launch the highest potential projects emerging from U-M. The academic inventors are rarely the right person to launch these startups. 🌎 When you sign on, the U-M ecosystem will help create momentum: an incubator to develop and launch, entrepreneurial advisors, ventures team, investment funds, and the world’s strongest network of alumni with industry talent and investors.   💸 As a U-M spin-off, several funds are available for investment including Accelerate Blue (ABF), Michigan Biomedical Venture Fund (MBVF), MUICF, MINTS (yes we love our acronyms), which collectively manage $100M+, focused on startups emerging from the U-M ecosystem. The University and the State are doubling down on startups as a priority. Questions: 🔸 Do I need to be based in MI? No! We are looking for the most capable entrepreneurs anywhere to lead these projects (most MBVF startups are based in Michigan, but we have several in California, Boston, Chicago, etc) 🔸 Do I need to be an alum? No! But we may adopt you as a Wolverine … and you might even find yourself saying “Go Blue!” See info linked below - and check in with my UM colleagues for more details (Dave Repp, Sarah Jameson-Valencia, Michael Psarouthakis, Kelly Sexton, etc.) “By connecting top entrepreneurial talent with U-M technologies, the program will accelerate the path to startup launch and foster new ventures that have the opportunity to solve the world’s great challenges.” A few example projects: 🔹 New Oral Immunotherapy Platform for the treatment of Food Allergies and Other Autoimmune Diseases 🔹 Generative AI Summarization for Dynamic Tracking of Clinical Symptoms 🔹 Gastrointestinal (GI) Locally-Activating JAK Inhibitor for Treatment of Ulcerative Colitis 🔹 Generation of Human Sertoli Cells to Support In Vivo and In Vitro Gametogenesis

For the tenth year in a row, the University of Michigan’s entrepreneurial ecosystem has earned a spot in the top 10 worldwide in The Princeton Review and Entrepreneur Magazine rankings! Learn about U-M’s entrepreneurship offerings: myumi.ch/xq4PA

On Wednesday we had our third MBVF lecture with guest speaker Connie Chang from ONL Therapeutics. She gave a great talk on the "Power of Choice: Integrating Big Pharma, Small Biotech, and Academic Research," clarifying the skills and perspectives needed in different size organizations and how to navigate career changes. Thank you to Michigan Biomedical Venture Fund for once again partnering with Nucleate to provide the food. The last lecture of this series will be on December 4th, with more information to come. Interested in venture capital and gaining hands on experience? The deadline to apply for the Nucleate Michigan x MBVF Venture Capital fellowship is today! As a Fellow, you’ll: - Generate technology landscaping reports in a defined target area - Explore a subsection of innovation at the University of Michigan - Work alongside MBVF experts in due diligence, gaining key venture capital insights 🔗 Apply to the Nucleate X MBVF Venture Fellowship here: https://lnkd.in/gMSdwYFn

📢 Attention, MedTech innovators! If you’re ready to make an impact with your cutting-edge medical technology, now is your chance. Applications for MedTech Innovator 2025 are officially OPEN! Don’t miss this opportunity to showcase your innovation—submit by January 15. Apply here: https://lnkd.in/ee_wfNq Join our first information session alongside BioTools Innovator on Nov 18th @ 9AM PT to get your questions asked. Register here 👉 https://lnkd.in/gqSy7PtG

🧬 Interested in Life Science Entrepreneurship at U of Michigan? 🧬 I've been collaborating with Nucleate Michigan (student bio-entrepreneurship org) on a speaker series and venture fellowship program. I’m very excited about the next speaker Connie Chang on Nov 13 ... see you there! 💊 "The Power of Choice: Integrating Big Pharma, Small Biotech, and Academic Research" 🔹 Connie Chang is a force of nature in Michigan's biotech ecosystem, currently COO at ONL Therapeutics, focused on therapies for eye diseases and causes of blindness like age-related macular degeneration (AMD). Previously VP at Millendo Therapeutics, Managing Director at University of Michigan's Medical Innovation group (FFMI), Sr Director at Sepracor Inc, with earlier roles at Pfizer. She is on the boards of the Van Andel Institute and the Regenerative Medicine Resource Center, a collaboration between University of Michigan, University of Pittsburgh, and Wyss Institute at Harvard University. BA in Psychobiology + MBA from Harvard. 🔗 Register here: https://lu.ma/8rbuvwsk 🧬 Nucleate X MBVF Venture Fellowship 🧬 For students seeking hands-on experience in venture capital, check out the Nucleate X MBVF Venture Fellowship. We are recruiting students to become part-time MBVF team members for this highly selective program (7-10 hr per week, paid). It's an incredible opportunity to gain practical experience evaluating startups, making investments, and supporting portfolio companies. Even if entrepreneurship is your ultimate goal, learning to think like a VC is invaluable. 🔹 Michigan Biomedical Venture Fund (MBVF) is a $15M early-stage life science fund that has invested in 18 companies, 1 exit, the portfolio startups have an aggregate valuation >$500M. We have seen $40+ raised by startups for every $1 MBVF investment. MBVF supports and invests in bio / med / health startups emerging from the University of Michigan — and supports life science entrepreneurship initiatives. We are part of the University of Michigan Center for Entrepreneurship (CFE) and University of Michigan Medical School Office of Research - FFMI. 🔹 Nucleate is a global, student-run life science entrepreneurship organization empowering the next generation of biotech innovators. With chapters across major hubs like Boston, the Bay Area, New York, and Michigan, Nucleate connects academic trainees with the resources and mentorship needed to launch new ventures. 🔗 Apply to the Nucleate X MBVF Venture Fellowship here (Nov 15 deadline): https://lnkd.in/gMSdwYFn

📢 Meet the 3rd Nucleate Michigan x Michigan Biomedical Venture Fund Fellowship Lecture Speaker: Connie Chang. Michigan Biomedical Venture Fund (MBVF) Fellowship Series is a 6-month fellowship, co-hosted with Nucleate Michigan, that gives students hands-on experience in technology landscaping and venture capital within life sciences, guiding fellows in startup navigation and sourcing at UM. Join us for the third lecture on "The Power of Choice: Integrating Big Pharma, Small Biotech, and Academic Research" by our speaker, Connie Chang from ONL Therapeutics. Connie Chang is the COO of ONL Therapeutics, focusing on therapies for eye diseases like retinal detachment and glaucoma. Previously, she was VP of Corporate Affairs at Millendo Therapeutics, overseeing investor relations and global operations. Connie also served as managing director of the innovation group at the University of Michigan Medical School and Senior Director for sleep and respiratory at Sepracor, with earlier roles in allergy, cardiovascular, and CNS at Pfizer. She is on the boards of the Van Andel Institute and the Michigan Pittsburgh Wyss Regenerative Medicine Resource Center, collaborating with the University of Michigan, University of Pittsburgh, and Harvard's Wyss Institute. Connie earned a BA in psychobiology from Harvard, graduating magna cum laude and Phi Beta Kappa, and an MBA from Harvard Business School. 📅 Date: Wednesday, November 13 ⏰ Time: 6:00 PM - 8:00 PM 📍 Location: Biological Sciences Building; 1105 N University Ave, Ann Arbor, MI 48109, USA; Room 1010 📝 Register here: https://lu.ma/8rbuvwsk We are looking forward to seeing you there!